Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Short-term Investments (2017 - 2026)

Kiniksa Pharmaceuticals International filings provide 7 years of Short-term Investments readings, the most recent being $278.1 million for Q1 2026.

  • On a quarterly basis, Short-term Investments rose 150.11% to $278.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $278.1 million, a 150.11% increase, with the full-year FY2025 number at $248.5 million, up 313.81% from a year prior.
  • Short-term Investments hit $278.1 million in Q1 2026 for Kiniksa Pharmaceuticals International, up from $248.5 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $278.1 million in Q1 2026 to a low of $25.0 million in Q3 2022.
  • Median Short-term Investments over the past 5 years was $98.4 million (2023), compared with a mean of $111.1 million.
  • Biggest five-year swings in Short-term Investments: soared 39068.1% in 2022 and later tumbled 38.99% in 2024.
  • Kiniksa Pharmaceuticals International's Short-term Investments stood at $67.9 million in 2022, then skyrocketed by 44.96% to $98.4 million in 2023, then plummeted by 38.99% to $60.0 million in 2024, then surged by 313.81% to $248.5 million in 2025, then increased by 11.94% to $278.1 million in 2026.
  • The last three reported values for Short-term Investments were $278.1 million (Q1 2026), $248.5 million (Q4 2025), and $177.2 million (Q3 2025) per Business Quant data.